Skip to main content
Clinical Trials/CTRI/2024/03/064485
CTRI/2024/03/064485
Recruiting
未知

Impact of yoga asanas, on quality of life of patients with type 2 diabetes and non- alcoholic fatty liver disease (NAFLD): a hospital based (quasi experiment) study. - NI

Charu Paliwal0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: E116- Type 2 diabetes mellitus with other specified complications
Sponsor
Charu Paliwal
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Charu Paliwal

Eligibility Criteria

Inclusion Criteria

  • A man or woman 30\-60 years old both inclusive who has been diagnosed with T2DM and NAFLD
  • Based on their medical history physical examination and laboratory tests participants must be medically stable
  • Participants must be capable of and willing to follow prohibitions and guidelines outlined in this protocol
  • Each participant must sign an informed consent form ICF attesting to their understanding of the studys goals and their willingness to take part in the study
  • Participant with fibroscan grading from 0 to 2
  • Participant with HbA1c between more than 7 to 10

Exclusion Criteria

  • A physical condition that significantly limits mobility wheelchair waking aid walking stick, cane or crutches)
  • Participant on insulin therapy
  • Trying to conceive or currently pregnant women or pregnant women with gestational diabetes
  • Highly uncontrolled diabetes HbA1c more than 10\.0 percent
  • Evidence of other forms of liver disease apart from NAFLD or other chronic disease
  • Prior history of gastric bypass surgery or any other surgery
  • Recent start of any SGLT\-2 inhibitor within 90 days of randomization or recent initiation or change of any anti\-diabetic medication that affects liver fat
  • 8\.Participation in a weight loss/diet programme within 12 months of the screening or usage of prescription or over\-the\-counter weight\-loss medication within 3 months of the screening

Outcomes

Primary Outcomes

Not specified

Similar Trials